Dr. Martens (DOCS)

Sector:

Personal Goods

Index:

FTSE 250

77.35p
   
  • Change Today:
    -0.45p
  • 52 Week High: 171.20p
  • 52 Week Low: 67.00p
  • Currency: UK Pounds
  • Shares Issued: 961.94m
  • Volume: 347,863
  • Market Cap: £744.06m

Dr Martens appoints Giles Wilson as CFO

By Michele Maatouk

Date: Tuesday 14 Nov 2023

LONDON (ShareCast) - (Sharecast News) - Iconic bootmaker Dr Martens said on Tuesday that it has appointed Giles Wilson as chief financial officer.
Wilson will take up his new role next year, with the date to be confirmed and announced "in due course".

The experienced CFO joins Dr Martens from spirits company William Grant & Sons Limited, which owns premium brands including Glenfiddich Scotch Whisky, The Balvenie Whisky and Hendrick's Gin. Prior to this, Wilson was at John Menzies as CFO between 2016 and 2020, and then subsequently became CEO from 2019 to 2020.

He qualified as a chartered accountant with PwC and previously held a senior role at Commercial Estates Group.

Chair Paul Mason said: "Following a rigorous selection process, we are delighted to appoint Giles as CFO. He is a very capable finance leader with extensive experience in a number of sectors and, most recently, his time in the branded spirits industry has given him a good grounding in global brands and wholesale distribution management.

"His knowledge of the public markets will be a valuable asset to the team as Dr Martens continues its growth in the listed environment. I look forward to him joining the board."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Dr. Martens Market Data

Currency UK Pounds
Share Price 77.35p
Change Today -0.45p
% Change -0.58 %
52 Week High 171.20p
52 Week Low 67.00p
Volume 347,863
Shares Issued 961.94m
Market Cap £744.06m

Dr. Martens Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
59.61% above the market average59.61% above the market average59.61% above the market average59.61% above the market average59.61% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Price Trend
80.3% below the market average80.3% below the market average80.3% below the market average80.3% below the market average80.3% below the market average
69.23% below the sector average69.23% below the sector average69.23% below the sector average69.23% below the sector average69.23% below the sector average
Income
65.12% above the market average65.12% above the market average65.12% above the market average65.12% above the market average65.12% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
4.76% below the market average4.76% below the market average4.76% below the market average4.76% below the market average4.76% below the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average

Dr. Martens Dividends

  Latest Previous
  Interim Final
Ex-Div 04-Jan-24 08-Jun-23
Paid 02-Feb-24 18-Jul-23
Amount 1.56p 4.28p

Trades for 08-May-2024

Time Volume / Share Price
16:05 5 @ 77.60p
16:00 694 @ 77.35p
16:00 1,000 @ 77.35p
16:00 261 @ 77.30p
16:00 219 @ 77.30p

Dr. Martens Key Personnel

Chair Paul Mason
CEO Kenny Wilson

Top of Page